Related Experiment Videos
Increased thymidine uptake by methylcholanthrene-treated C3H/10T1/2 cells
International Journal of Cancer
|September 15, 1975
Summary
Transformed mouse cells show higher 3H-thymidine uptake than normal cells. This difference can detect even small percentages of transformed cells, aiding cancer research.
Area of Science:
- Cell Biology
- Cancer Research
- Biochemistry
Background:
- Chemical carcinogens like methylcholanthrene induce cellular transformation.
- Distinguishing transformed cells from normal cells is crucial for understanding carcinogenesis.
- Thymidine incorporation is a measure of DNA synthesis and cell proliferation.
Purpose of the Study:
- To investigate the difference in 3H-thymidine uptake between methylcholanthrene-transformed and non-transformed mouse embryo cells.
- To determine the sensitivity of thymidine uptake assays for detecting transformed cells.
- To correlate thymidine uptake with the morphological changes indicative of transformation.
Main Methods:
- Culturing of methylcholanthrene-transformed C3H/10T1/I mouse embryo cells and their non-transformed counterparts.
- Measuring 3H-thymidine uptake in post-confluent cell cultures over 110 days.
- Performing reconstruction experiments with varying percentages of transformed cells.
- Observing and quantifying Type III transformed foci.
Main Results:
- Significantly higher 3H-thymidine uptake was observed in transformed cells compared to non-transformed cells.
- As little as 2% transformed cells could be detected through increased thymidine uptake.
- Elevated thymidine incorporation in methylcholanthrene-treated cultures persisted for up to 110 days and correlated with Type III foci formation.
Conclusions:
- 3H-thymidine uptake is a sensitive marker for detecting chemically induced cellular transformation in mouse embryo cells.
- This method allows for early detection and quantification of transformed cells in culture.
- The findings support the use of thymidine uptake assays in cancer research and the study of chemical carcinogenesis.